Featured market report: Summary of dry eye syndrome
November 5, 2015dry eye disease, dry eye syndrome, lifitegrast
This report provides the current prevalent population for dry eye syndrome across seven major markets.It includes data for the USA, …
Sanofi and Hanmi partner to create long-acting diabetes treatments
November 5, 2015Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi
Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …
OECD report warns of high spend and slow growth for pharma industry
November 5, 2015Manufacturing and Production, Sales and Marketing OECD, pharmaceutical spending
The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …
Obama government launches drug price crackdown
November 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access
President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …
NHS England reinstates treatments to Cancer Drugs Fund
November 4, 2015Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NHS England
Five treatments in seven indications have been reinstated to Cancer Drugs Fund, as a result of negotiations between pharma companies …
Novo Nordisk invests in new insulin-filling facility
November 4, 2015Manufacturing and Production Denmark, Novo Nordisk, manufacturing, production
Novo Nordisk is investing 2.1 billion Danish Kroner (about £200m) in a new facility in Hillerød, Denmark, which will produce diabetes …
Merck appoints Laszlo Radvanyi as head of global immuno-oncology research
November 4, 2015Research and Development Laszlo Radvanyi, Merck
Dr Laszlo Radvanyi has joined Merck as senior vice president and head of research in immuno-oncology. The Merck Group says …
GSK plots return to growth with launch of 20 new drugs by 2020
November 4, 2015Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline
GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …
Drugs later in development ‘winning the race to market’
November 4, 2015Research and Development R&D, drug approval, drug development, market exclusivity
Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …
Pfizer approached GSK for takeover before Allergan
November 4, 2015Research and Development, Sales and Marketing Allergan, GSK, Pfizer, financial results, product pipeline
Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …
Bristol-Myers Squibb enters academic R&D tie-up
November 4, 2015Research and Development BMS, Bristol-Myers Squibb, Cardioxy, John Hopkins, acquisition, immunooncology, job losses
Bristol-Myers Squibb and The Johns Hopkins University have entered into a collaboration agreement, as part of the pharma firm’s rare …
Novo Nordisk forms academic partnership with Washington Uni
November 4, 2015Research and Development Novo Nordisk, diabetes, obesity
Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …
Putting off-patent drugs back to work
November 4, 2015Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents
Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …
GSK and Merck to study immunotherapy combo in solid tumours
November 3, 2015Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I
GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …
Pharma R&D hub BioCity appoints new CFO
November 3, 2015Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver
BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …
Sanofi claims $109m impact on revenue following recall
November 3, 2015Manufacturing and Production Sanofi, finance, maufacturing, product recall
As Sanofi recalls its Auvi-Q epinephrine injection for the treatment of severe allergic reactions – after the company found the …
EU plans export waiver for pharma manufacturing
November 3, 2015Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates
The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …
Sanofi and BioNTech in cancer immunotherapy partnership
November 3, 2015Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy
Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …
Mylan appoints a global commercial lead for OTC business
November 3, 2015Manufacturing and Production Mylan, OTC, Ranjan Ray Chaudhuri, over the counter
Mylan has appointed Ranjan Ray Chaudhuri as its new global commercial lead for the company’s over-the-counter (OTC) business. Chaudhuri will …
FDA alleges records cover-up at Chinese Pfizer plant
November 3, 2015Manufacturing and Production FDA, Pfizer, compliance, inspection, manufacturing, production, regulations
The FDA has discovered violations at a Pfizer plant in China, including the use of out-of-date materials and record- keeping …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
